ReviewLe infezioni in medicina2023

Pharmacological outlook of Lenacapavir: a novel first-in-class Long-Acting HIV-1 Capsid Inhibitor.

Giovanni Di PerriPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.